铱
光敏剂
化学
光动力疗法
活性氧
光化学
可见光谱
辐照
生物物理学
光电子学
生物化学
催化作用
有机化学
物理
生物
核物理学
作者
Callum G. Jones,Marta Martínez-Alonso,Hannah Gagg,Liam Kirby,Julia A. Weinstein,Helen E. Bryant
标识
DOI:10.1021/acs.jmedchem.4c00869
摘要
High Resolution Image Download MS PowerPoint Slide Photodynamic therapy delivers more targeted cell killing than classical chemotherapy. It uses light-absorbing compounds, photosensitizers (PSs), to generate lethal reactive oxygen species (ROS) at sites of localized irradiation. Transition metal complexes are attractive PSs due to their photostability, visible-light absorption, and high ROS yields. Here, we introduce a low-molecular weight, photostable iridium complex, [Ir(thpy) 2 (benz)]Cl, 1, that localizes to the Golgi apparatus, mitochondria, and endoplasmic reticulum, absorbs visible light, phosphoresces strongly, generates 1 O 2 with 43% yield, and undergoes cellular elimination after 24 h. 1 shows low dark toxicity and under remarkably low doses (3 min, 20–30 mJ s –1 cm –2 ) of 405 or 455 nm light, it causes killing of bladder (EJ), malignant melanoma (A375), and oropharyngeal (OPSCC72) cancer cells, with high phototoxic indices > 100–378. 1 is also an efficient PS in 3D melanoma spheroids, with repeated short-time irradiation causing cumulative killing.
科研通智能强力驱动
Strongly Powered by AbleSci AI